Source: Annual Congress 2013 –Difficult and rare respiratory infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Numbere, M. Bhattacharya, A. Kavidasan (Milton Keynes, United Kingdom). Is CRP a reliable diagnostic tool for infective exacerbations of COPD?. Eur Respir J 2013; 42: Suppl. 57, 2070

Member's Comments

No comment yet.

Related content which might interest you: Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014 Eosinophilia as marker of outcome in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD and infections Year: 2013 The predictors for COPD exacerbations using remote patient monitoring Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 BNP level in patients with COPD exacerbations Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013